MPO and vasculitis: Interestingly, deficiency of C6, a component of membrane attack complex (MAC), has no effect on development of vasculitis, and C5a receptor deficiency and treatment with a C5a receptor antagonist ameliorates MPO-ANCA-induced vasculitis (48).